Abstract:BACKGROUND:Cytomegalovirus (CMV) infection is the important cause affecting the survival rate and function of the transplanted organ after transplantation. The occurrence of CMV infection after liver transplantation (LT) is associated with many factors. Lots of studies suggest that genetic mutation between hosts and CMV may play a role in the occurrence and development of CMV infection. CMV exists in an incubative state, affect or destroy the expression of human leukocyte antigen (HLA) molecules in the host cell surface, and interfere antigen's submission. This mechanism is the key of CMV to avoid immune defense mechanism of the host. To detect HLA and CMV antibody (CMV-Ab), CMV antigen (CMV-Ag) of transplantation recipients, we evaluated the association of CMV infection and the particular HLA genotypes in recipients after LT.METHODS:277 blood samples were collected from 39 LT recipients. CMV antibody and antigen were detected by ELISA or immunohistochemical methods. The HLA types of the recipients were determined by PCR. To analyze the association of HLA alleles and the occurrence of CMV antigenemia in the patients, relative risk degree (RR) was used as the parameter for the Chi-square test.RESULTS:The LT recipients were serum CMV IgG positive (100%), but none of them was CMV IgM positive (0%). Thirty-three LT recipients (84.6%) were CMV antigenic positive with 1-50 positive leukocytes per 50,000 leukocytes in extent and 7.2+/-4.2 positive leukocytes per 50,000 leukocytes on average. Thirteen patients developed CMV pneumonia, with CMV antigenic positive (100%) and 17.7+/-5.5 positive leukocytes per 50,000 leukocytes on average. Some HLA alleles were associated with the occurrence and extent of CMV antigenemia. HLA-A2 was the higher frequency allele for patients with antigenemia (P<0.05), and 7 patients carrying HLA-DR11 allele developed antigenemia (P<0.05). In the lower antigenemia group, HLA-A11 was higher in frequency than others (P<0.05). Besides, none of the patients carrying HLA-B16 allele developed clinical symptoms of CMV infection (P<0.05).CONCLUSIONS:The variability of HLA alleles might modulate immune response to CMV infection. HLA examination before transplantation should be made for prevention and treatment of CMV infection after operation.

A New Mutation in the Human Cytomegalovirus UL97 Gene May Confer Ganciclovir Resistance in Chinese Kidney Transplant Recipients

Prevalence of Human Cytomegalovirus UL97 D605E Mutation in Transplant Recipients in China

Detection of Human Cytomegalovirus UL97 Gene Mutations Conferring Ganciclovir Resistance

Human Cytomegalovirus (CMV) UL97 D605E Mutation Has a Higher Prevalence in Infants with Primary CMV Infection Compared with Transplant Recipients with CMV Recurrence

Progress on the association between human gene polymorphisms and cytomegalovirus infection after transplantation

The Polymorphism Disparity of Cytomegalovirus UL97 Gene in Pediatric Patients, Renal-Transplanted, and Hematopoietic Stem Cell Transplanted Recipients

Construction and identification of recombinant human cytomegalovirus with ganciclovir-resistance associated mutations in UL97 gene

The establishment and application of the method for identifying ganciclovir-resistant genotypes of Human cytomegalovirus

Molecular Detection and Genotyping of Human Cytomegalovirus in Kidney Transplant Recipients under Ganciclovir Prophylaxis in Iran

Ganciclovir-induced mutations are present in a diverse spectrum of post-transplant malignancies

Cytomegalovirus Glycoprotein B Sequence Variation in Chinese Liver Transplant Recipients.

Dynamics and Evolution of Donor-derived Cytomegalovirus Infection in 3 Solid Organ Transplant Recipients With the Same Multiorgan Donor

The Impact of Pretransplant Cytomegalovirus Infection on Acute Renal Allograft Rejection

Association of Cytomegalovirus Infection with Human Leukocyte Antigen Genotypes in Recipients after Allogeneic Liver Transplantation.

Analysis of the Ganciclovir-Resistant Phenotype of Human Cytomegalovirus Clinical Isolates

Molecular Epidemiology of Cytomegalovirus UL97 and UL54 variants in Taiwan

Genetic Variation Within the Glycoprotein B and H Genes of Human Cytomegalovirus in Solid Organ Transplant Recipients

Treatment Of Cytomegalovirus Infection After Renal Transplantation: Experience From A Single Center In China

Detection of Two Drug-Resistance Mutants of the Cytomegalovirus by High-Resolution Melting Analysis

Cytomegalovirus involving gastrointestinal tract in renal transplant recipients

Characterising variation in five genetic loci of cytomegalovirus during treatment for congenital infection